{"url_path":"/sec/krro/8-k/2026-05-19/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-19","source_url":"https://www.sec.gov/Archives/edgar/data/1703647/0001193125-26-229610-index.html","accession_number":"0001193125-26-229610","cik":"0001703647","ticker":"KRRO","issuer_name":"Korro Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1703647/0001193125-26-229610-index.html","primary_entity_key":"0001703647","primary_entity_name":"Korro Bio, Inc."},"word_count":105,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\nExhibit\n\nNo.\n\n \n\nDescription\n\n \n\n \n\n \n\n99.1\n\n \n\n[Press Release issued by Korro Bio, Inc., dated May 19, 2026](krro-ex99_1.htm)\n\n99.2\n\n \n\n[Selected Slides from Corporate Presentation of Korro Bio, Inc., dated May 19, 2026](krro-ex99_2.htm)\n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\nKORRO BIO, INC.\n\n \n\n \n\nDate: May 19, 2026\n\nBy:\n\n/s/ Ram Aiyar\n\n \n\n \n\n \n\n \n\n \n\nName: Ram Aiyar\n\n \n\n \n\nTitle: President and Chief Executive Officer and Interim Chief Financial Officer"}